%0 Journal Article
%T Intratumor DNA methylation heterogeneity in glioblastoma: implications for DNA methylation-based classification
%A Anna Wenger
%A Asgeir Store Jakola
%A Helena Car¨Śn
%A Sandra Ferreyra Vega
%A Teresia Kling
%A Thomas Olsson Bontell
%J Archive of "Neuro-Oncology".
%D 2019
%R 10.1093/neuonc/noz011
%X A feature of glioblastoma (GBM) is cellular and molecular heterogeneity, both within and between tumors. This variability causes a risk for sampling bias and potential tumor escape from future targeted therapy. Heterogeneous intratumor gene expression in GBM is well documented, but little is known regarding the epigenetic heterogeneity. Variability in DNA methylation within tumors would have implications for diagnostics, as methylation can be used for tumor classification, subtyping, and determination of the clinically used biomarker O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation. We therefore aimed to profile the intratumor DNA methylation heterogeneity in GBM and its effect on diagnostic properties
%K classification
%K DNA methylation
%K glioblastoma
%K heterogeneity
%K MGMT
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6502500/